RxDoctor Payments Data

Gabrielle Barnes, MD

Sleep Medicine · Orlando, FLNPI 1548603566

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 32.0% of the total. 2025 is the largest year on record at $1,122, 8.1 times the $138 reported in 2023. That places this record below the midpoint for sleep medicine clinicians in FL, where the typical reported total is $1,804.

$2,116in general payments, 2019–2025

Across 76 payments — averaging $27.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$676
  • GSK$348
  • AstraZeneca$187
  • Insmed, Inc.$157
  • Baxter Healthcare$113
  • Pulmonx Corporation$103
  • plus $532 from 11 others

What the payments were for

  • Food & beverage$2,08198%
  • Education$352%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,116 in reported general payments places this provider in the 50th percentile of 77 sleep medicine providers in Florida.

See all sleep medicine providers in Florida

Medicare billing

Part B allowed, 2024
$46,617
Medicare patients
168
Services billed
378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$24,257
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$11,118
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$2,902
Albuterol Sulfate HfaAlbuterol Sulfate17$457
Fluticasone Propionate25$299
Ipratropium Bromide12$276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$348$24,25731 claims
AstraZenecaBreztri Aerosphere$187$11,11812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 77 sleep medicine providers in Florida.

Other sleep medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →